These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32562548)
1. External validation of a model to predict risk of keratinocyte skin cancer after renal transplantation in a Western European cohort. Verhage EJ; Nelemans PJ; van Kuijk SMJ; Christiaans MHL; Kelleners-Smeets NWJ Br J Dermatol; 2020 Dec; 183(6):1110-1112. PubMed ID: 32562548 [No Abstract] [Full Text] [Related]
2. Association between betapapillomavirus seropositivity and keratinocyte carcinoma-prospects for prophylactic vaccination? Pfister H J Invest Dermatol; 2015 May; 135(5):1211-1213. PubMed ID: 25882460 [TBL] [Abstract][Full Text] [Related]
3. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Naldi L; Fortina AB; Lovati S; Barba A; Gotti E; Tessari G; Schena D; Diociaiuti A; Nanni G; La Parola IL; Masini C; Piaserico S; Peserico A; Cainelli T; Remuzzi G Transplantation; 2000 Nov; 70(10):1479-84. PubMed ID: 11118094 [TBL] [Abstract][Full Text] [Related]
5. [Risk factors and development of skin neoplasms in patients after kidney transplantation]. Sułowicz J; Krzanowski M; Wojas-Pelc A Przegl Lek; 2005; 62(7):698-702. PubMed ID: 16463705 [TBL] [Abstract][Full Text] [Related]
6. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621 [TBL] [Abstract][Full Text] [Related]
7. Development of malignancy following renal transplantation in Australia and New Zealand. Sheil AG Transplant Proc; 1992 Aug; 24(4):1275-9. PubMed ID: 1496562 [No Abstract] [Full Text] [Related]
8. Cutaneous neoplasm and its relationship with factors due to renal transplant. Bayés B; Lauzurica R; Fuente MJ; Bonet J; Ribera M; Romero R; Ferrandiz C Transplant Proc; 1999 Sep; 31(6):2317-8. PubMed ID: 10500596 [No Abstract] [Full Text] [Related]
9. Skin cancer in transplant recipients. McGregor JM; Proby CM Lancet; 1995 Oct; 346(8980):964-5. PubMed ID: 7564745 [No Abstract] [Full Text] [Related]
10. The epidemiology of transplant-associated keratinocyte cancers in different geographical regions. Proby CM; Wisgerhof HC; Casabonne D; Green AC; Harwood CA; Bouwes Bavinck JN Cancer Treat Res; 2009; 146():75-95. PubMed ID: 19415194 [No Abstract] [Full Text] [Related]
11. Skin cancer after renal transplantation: Results of a multicenter study in Iran. Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266 [TBL] [Abstract][Full Text] [Related]
12. Malignancy following renal transplantation. Sheil AG; Disney AP; Mathew TG; Amiss N; Excell L Transplant Proc; 1992 Oct; 24(5):1946-7. PubMed ID: 1412921 [No Abstract] [Full Text] [Related]
13. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. Salim A; Reece SM; Smith AG; Harrison D; Ramsay HM; Harden PN; Fryer AA J Am Acad Dermatol; 2006 Nov; 55(5):878-81. PubMed ID: 17052497 [TBL] [Abstract][Full Text] [Related]
14. Cancer development in pediatric primary renal allograft recipients. Gruber SA; Gillingham K; Sothern RB; Stephanian E; Chavers B; Matas AJ; Dunn DL Transplant Proc; 1994 Feb; 26(1):3-4. PubMed ID: 8108991 [No Abstract] [Full Text] [Related]
15. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126 [TBL] [Abstract][Full Text] [Related]
16. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study. Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261 [TBL] [Abstract][Full Text] [Related]
17. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160 [No Abstract] [Full Text] [Related]
18. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. Jensen P; Møller B; Hansen S J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):307. PubMed ID: 10642700 [No Abstract] [Full Text] [Related]
19. A Model to Predict the Risk of Keratinocyte Carcinomas. Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM; J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057 [TBL] [Abstract][Full Text] [Related]
20. Special malignancy pattern in Chinese renal transplantation recipients: a single center experience and literature review. Sun Q; Li X; Cheng D; He Q; Chen J; Ji S; Liu Z Asian Pac J Cancer Prev; 2011; 12(12):3347-51. PubMed ID: 22471478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]